glp 1 receptor brain A schematic representation of the potential role of GLP-1 GLP-1 and the Degenerating Brain:

Medicine and lifestyle must work together, not replace each other GLP1 agonists are currently used more in the treatment of obesity than diabetes...they have created a good market in the obesity sector

No protocol, treatment, supplement, or plan can work at its full potential if the bodys foundations are weak

avoid foaming

Retatrutide, a GIP/GLP-1/Glucagon receptor agonist (GGG tri-agonist) in development by Eli Lilly and Company, isnt on the market yet

Your body is adjusting to a fundamentally different pace of digestion, and that adjustment takes time

Join the community April 9-12, 2026 at Medical Spa Show to connect, collaborate and come away with new techniques to level up your clinical and operational excellence